Terms: = Ovarian cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776
54 results:
1.
Bao S; Sun N; Li Y; Shu J; Xu J; Zhang Y; Qiu X
J Int Med Res; 2024 Jan; 52(1):3000605231223426. PubMed ID: 38263931
[TBL] [Abstract] [Full Text] [Related]
2. Morphological Changes of the ovarian Vein in Pelvic Venous Disorders.
Nykonenko A; Trailin A; Lazarashvili Z; Proczka RM; Havrylenko B; Nykonenko O
Eur J Vasc Endovasc Surg; 2024 Mar; 67(3):500-505. PubMed ID: 37952635
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a predictive model of abnormal uterine bleeding associated with ovulatory dysfunction: a case-control study.
Zhang Y; Luo Z; Jia Y; Zhao Y; Huang Y; Ruan F; Ying Q; Ma L; Luo J; Zhou J
BMC Womens Health; 2023 Oct; 23(1):536. PubMed ID: 37828525
[TBL] [Abstract] [Full Text] [Related]
4. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
[TBL] [Abstract] [Full Text] [Related]
5. Germline Mutations in 12 Genes and Risk of ovarian cancer in Three Population-Based Cohorts.
Kotsopoulos J; Hathaway CA; Narod SA; Teras LR; Patel AV; Hu C; Yadav S; Couch FJ; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1402-1410. PubMed ID: 37493628
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence.
Liu Y; Chen J; Lu Z; Chang X; Wang P; Ma H; Chen X; Mo S; Lv Z; Mao X; Zong L; Yu S; Chen J
Gynecol Oncol; 2023 Sep; 176():106-114. PubMed ID: 37481922
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective study.
Yang X; Yin J; Fu Y; Shen Y; Zhang C; Yao S; Xu C; Xia M; Lou G; Liu J; Lin B; Wang J; Zhao W; Zhang J; Cheng W; Guo H; Guo R; Xue F; Wang X; Han L; Li X; Zhang P; Zhao J; Li W; Dou Y; Wang Z; Liu J; Li K; Chen G; Sun C; Sun P; Lu W; Yao Q
Diagn Pathol; 2023 Jan; 18(1):8. PubMed ID: 36698195
[TBL] [Abstract] [Full Text] [Related]
8. ROMA Index Is an Effective Predictor for Advanced Endometrial cancer before Surgery.
Wang J; Xu P; Zou G; Yin M; Mao X; Zhang X
Dis Markers; 2022; 2022():7409368. PubMed ID: 36590753
[TBL] [Abstract] [Full Text] [Related]
9. A systematic review on isolated coil embolization for pelvic venous reflux.
Sutanto SA; Tan M; Onida S; Davies AH
J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):224-232.e9. PubMed ID: 34358670
[TBL] [Abstract] [Full Text] [Related]
10. Gross mucinous multinodular appearance aids in the identification of ovarian metastases in low-grade appendiceal mucinous neoplasms during intraoperative consultation.
Yoshida H; Tanaka H; Tsukada T; Abeto N; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Ann Diagn Pathol; 2021 Feb; 50():151641. PubMed ID: 33189966
[TBL] [Abstract] [Full Text] [Related]
11. Dietary glycemic index, glycemic load and risk of bladder cancer: a prospective study.
Xu X; Shivappa N
Eur J Nutr; 2021 Mar; 60(2):1041-1048. PubMed ID: 32577885
[TBL] [Abstract] [Full Text] [Related]
12. Prognosis Trend of Grade 2 Endometrioid Endometrial Carcinoma: Toward Grade 1 or 3?
Khatib G; Gulec UK; Guzel AB; Bagir E; Paydas S; Vardar MA
Pathol Oncol Res; 2020 Oct; 26(4):2351-2356. PubMed ID: 32488809
[TBL] [Abstract] [Full Text] [Related]
13. Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Int J Gynaecol Obstet; 2020 Aug; 150(2):177-183. PubMed ID: 32469080
[TBL] [Abstract] [Full Text] [Related]
14. Higher platelet distribution width is associated with unfavorable prognosis in ovarian cancer.
Qin L; Li JY; Huang WJ; Zhang ML; Wang RT; Shen W
Cancer Biomark; 2020; 28(3):365-370. PubMed ID: 32417761
[TBL] [Abstract] [Full Text] [Related]
15. Dietary inflammatory index and bladder cancer risk: a prospective study.
Luo J; Shivappa N; Hébert JR; Xu X
Eur J Clin Nutr; 2020 Oct; 74(10):1428-1433. PubMed ID: 32203237
[TBL] [Abstract] [Full Text] [Related]
16. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose ovarian cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract] [Full Text] [Related]
17. Dietary fiber intake and the risk of bladder cancer in the Prostate, Lung, Colorectal and ovarian (PLCO) cohort.
Luo J; Xu X
Carcinogenesis; 2020 Jun; 41(4):478-482. PubMed ID: 31872237
[TBL] [Abstract] [Full Text] [Related]
18. Processed Meat Intake and Bladder cancer Risk in the Prostate, Lung, Colorectal, and ovarian (PLCO) Cohort.
Xu X
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):1993-1997. PubMed ID: 31533945
[TBL] [Abstract] [Full Text] [Related]
19. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract] [Full Text] [Related]
20. Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer.
Márton É; Lukács J; Penyige A; Janka E; Hegedüs L; Soltész B; Méhes G; Póka R; Nagy B; Szilágyi M
J Biotechnol; 2019 May; 297():58-65. PubMed ID: 30953675
[TBL] [Abstract] [Full Text] [Related]
[Next]
